\-\ Texto\\:\\ \ \(0\)\
\-\ edema\\ and\\ tenderness\\ over\\ right\\ small\\ finger\\,\\ proximal\\ phalanx\\.\\ limited\\ range\\ of\\ motion\\.\\ no\\ sensory\\ deficits\\.\ \(0\)\
\-\ observation\\ if\\ the\\ lesion\\ is\\ asymptomatic\\.\\ if\\ a\\ pathologic\\ fracture\\ is\\ present\\,\\ the\\ fracture\\ is\\ first\\ allowed\\ to\\ heal\\.\\ otherwise\\ once\\ healed\\,\\ or\\ if\\ the\\ tumor\\ becomes\\ symptomatic\\,\\ it\\ is\\ resected\\ with\\ subsequent\\ histological\\ tests\\ to\\ rule\\ out\\ malignancy\\,\\ and\\ the\\ extirpation\\ cavity\\ can\\ be\\ filled\\ with\\ autogenous\\ spongy\\ bone\\.\ \(0\)\
\-\ complete\\ fracture\\ of\\ the\\ right\\ fifth\\ proximal\\ phalanx\\ traversing\\ through\\ a\\ 0\\.94\\ x\\ 1\\.43cm\\ well\\-defined\\ geographic\\ medullary\\ lesion\\ with\\ lobulated\\ appearance\\ and\\ scalloping\\ of\\ the\\ adjacent\\ cortex\\.\\ appearance\\ consistent\\ with\\ a\\ geographic\\ 1b\\ lesion\\.\ \(0\)\
\-\ enchondroma\\ with\\ pathologic\\ fracture\ \(0\)\
\-\ geographic\\ 1b\\ lesion\\ \\(well\\-defined\\,\\ no\\ sclerosis\\)\\:\ \(0\)\
\-\ enchondroma\ \(73\)\
\-\ chondroblastoma\ \(12\)\
\-\ chondromyxoid\\ fibroma\ \(4\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ bone\\ cyst\ \(88\)\
\-\ giant\\ cell\\ tumor\ \(18\)\
\-\ myeloma\\/metastasis\ \(0\)\
\-\ 21\\ y\\.o\\.\\ man\\ presented\\ to\\ the\\ emergency\\ room\\ one\\ day\\ after\\ playing\\ flag\\ football\\.\\ he\\ remembers\\ hearing\\ a\\ pop\\ and\\ feeling\\ pain\\ in\\ his\\ right\\ small\\ finger\\ during\\ the\\ game\\.\ \(0\)\
\-\ a\\ chondroma\\ is\\ a\\ benign\\ neoplasm\\ of\\ hyaline\\ cartilage\\.\\ \\ when\\ it\\ arises\\ within\\ the\\ medullary\\ cavity\\ of\\ bone\\,\\ it\\ is\\ called\\ an\\ enchondroma\\.\\ multiple\\ echondromas\\,\\ or\\ enchondromatosis\\,\\ is\\ known\\ as\\ ollier\\ disease\\.\\ \\ if\\ the\\ enchondromatosis\\ is\\ associated\\ with\\ soft\\ tissue\\ hemangiomas\\,\\ this\\ is\\ known\\ as\\ maffucci\\ syndrome\\.\\ \ \(0\)\
\-\ these\\ lesions\\ typically\\ present\\ between\\ 20\\ and\\ 50\\ years\\ of\\ age\\ and\\ are\\ equally\\ frequent\\ in\\ men\\ and\\ women\\.\\ enchondromas\\ usually\\ occur\\ as\\ a\\ solitary\\ lesion\\ with\\ approximately\\ 40\\-65\\%\\ occurring\\ in\\ the\\ hands\\,\\ or\\ less\\ frequently\\,\\ the\\ feet\\.\\ solitary\\ enchondromas\\ also\\ occur\\ in\\ the\\ long\\ tubular\\ bones\\ in\\ approximately\\ 25\\%\\ of\\ cases\\,\\ more\\ frequently\\ in\\ the\\ upper\\ extremities\\ than\\ in\\ the\\ lower\\ extremities\\.\\ rare\\ areas\\ of\\ involvement\\ include\\ the\\ skull\\,\\ facial\\ bones\\,\\ patella\\,\\ clavicle\\,\\ sternum\\,\\ scapula\\,\\ ulna\\,\\ and\\ vertebrae\\.\\ a\\ general\\ rule\\ chondroid\\ lesions\\ of\\ the\\ axial\\ skeleton\\ are\\ chondrosarcomas\\.\\ \ \(0\)\
\-\ solitary\\ lesions\\ are\\ generally\\ asymptomatic\\ or\\ associated\\ with\\ painless\\ swelling\\.\\ often\\ these\\ tumors\\ go\\ unnoticed\\ and\\ are\\ found\\ incidentally\\ on\\ x\\-ray\\,\\ occasionally\\ associated\\ with\\ a\\ pathologic\\ fracture\\.\ \(0\)\
\-\ radiographic\\ features\\ of\\ solitary\\ enchondromas\\ in\\ the\\ hand\\ or\\ foot\\ are\\ characteristic\\.\\ a\\ well\\-defined\\,\\ medullary\\ lesion\\ with\\ lobulated\\ contour\\ and\\ endosteal\\ erosion\\.\\ cortical\\ expansion\\ or\\ thickening\\,\\ foci\\ of\\ calcification\\(but\\ lesions\\ of\\ the\\ hand\\ and\\ foot\\ are\\ frequently\\ not\\ mineralized\\)\\,\\ and\\ pathologic\\ fracture\\ are\\ also\\ possible\\ characteristics\\.\\ magnetic\\ resonance\\ imaging\\ typically\\ show\\ a\\ well\\-circumscribed\\,\\ lobulated\\ lesion\\ of\\ low\\ signal\\ intensity\\ \\(less\\ than\\ or\\ equal\\ to\\ skeletal\\ muscle\\)\\ on\\ t1\\-weighted\\ spin\\ echo\\,\\ and\\ high\\ signal\\ intensity\\ \\(similar\\ to\\ water\\)\\ on\\ t2\\-weighted\\ spin\\ echo\\.\ \(0\)\
\-\ solitary\\ lesions\\ rarely\\ undergo\\ malignant\\ transformation\\ into\\ chondrosarcomas\\,\\ however\\ lesions\\ associated\\ with\\ enchondromatosis\\ are\\ more\\ likely\\ to\\ undergo\\ sarcomatous\\ change\\ than\\ monostotic\\ lesions\\.\\ in\\ addition\\ to\\ sarcomatous\\ transformation\\,\\ those\\ with\\ maffucci\\ syndrome\\ are\\ also\\ at\\ risk\\ of\\ developing\\ other\\ malignancies\\ to\\ include\\ ovarian\\ carcinomas\\ and\\ brain\\ gliomas\\.\\ lesions\\ larger\\ than\\ 5\\ cm\\ in\\ diameter\\ are\\ much\\ more\\ likely\\ to\\ be\\ chondrosarcomas\\ and\\ patients\\ are\\ frequently\\ older\\ than\\ those\\ with\\ enchondroma\\.\\ \\ other\\ finding\\ in\\ long\\ bone\\ cartilage\\ lesions\\ to\\ suggest\\ chondrosarcoma\\ include\\ greater\\ than\\ 2\\/3\\ endosteal\\ scalloping\\,\\ cortical\\ thickening\\/remodeling\\,\\ or\\ soft\\ tissue\\ extension\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ solitary\\:\\ 0\\.03779685780270157\ \(0\)\
\-\ chondrosarcomas\\:\\ 0\\.03756020831410932\ \(0\)\
\-\ lesions\\:\\ 0\\.0366988316525767\ \(0\)\
\-\ enchondromas\\:\\ 0\\.033425503029438294\ \(0\)\
\-\ enchondromatosis\\:\\ 0\\.03302920371310823\ \(0\)\
\-\ geographic\\:\\ 0\\.031396146763636675\ \(0\)\
\-\ enchondroma\\:\\ 0\\.027154271688145076\ \(0\)\
\-\ pathologic\\:\\ 0\\.026669123769929918\ \(0\)\
\-\ frequently\\:\\ 0\\.026406635548021067\ \(0\)\
\-\ 1b\\:\\ 0\\.025690126600828513\ \(0\)\
\-\ maffucci\\:\\ 0\\.025690126600828513\ \(0\)\
\-\ fracture\\:\\ 0\\.02409705166067143\ \(0\)\
\-\ than\\:\\ 0\\.02394704657666603\ \(0\)\
\-\ sarcomatous\\:\\ 0\\.023594630469270152\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.023511646075774866\ \(0\)\
\-\ lobulated\\:\\ 0\\.022961122176029185\ \(0\)\
\-\ are\\:\\ 0\\.02284066416724709\ \(0\)\
\-\ medullary\\:\\ 0\\.021957156270877885\ \(0\)\
\-\ lesion\\:\\ 0\\.021718157900183926\ \(0\)\
\-\ spin\\:\\ 0\\.019812555743119485\ \(0\)\
\-\ endosteal\\:\\ 0\\.01954835619889944\ \(0\)\
\-\ scalloping\\:\\ 0\\.018752835516852348\ \(0\)\
\-\ transformation\\:\\ 0\\.01727353479648619\ \(0\)\
\-\ phalanx\\:\\ 0\\.01695214051130153\ \(0\)\
\-\ if\\:\\ 0\\.01653293000913109\ \(0\)\
\-\ finger\\:\\ 0\\.016132117585804302\ \(0\)\
\-\ cartilage\\:\\ 0\\.015850518971477635\ \(0\)\
\-\ echo\\:\\ 0\\.015850518971477635\ \(0\)\
\-\ extirpation\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ 0\\.94\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ 1\\.43cm\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ \\-enchondroma\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ \\-giant\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ \\-myeloma\\/metastasis\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ echondromas\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ unnoticed\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ thickening\\/remodeling\\:\\ 0\\.015713936584610514\ \(0\)\
\-\ undergo\\:\\ 0\\.015465888090867349\ \(0\)\
\-\ spongy\\:\\ 0\\.014478380113024159\ \(0\)\
\-\ \\-chondroblastoma\\:\\ 0\\.014478380113024159\ \(0\)\
\-\ \\-chondromyxoid\\:\\ 0\\.014478380113024159\ \(0\)\
\-\ 40\\-65\\:\\ 0\\.014478380113024159\ \(0\)\
\-\ \\,\\:\\ 0\\.014476474091833549\ \(0\)\
\-\ associated\\:\\ 0\\.014377629674921224\ \(0\)\
\-\ or\\:\\ 0\\.014281964334598324\ \(0\)\
\-\ those\\:\\ 0\\.013861906377216732\ \(0\)\
\-\ autogenous\\:\\ 0\\.013755625909622794\ \(0\)\
\-\ \\-fibrous\\:\\ 0\\.013755625909622794\ \(0\)\
\-\ cavity\\:\\ 0\\.013334561884964959\ \(0\)\
\-\ bones\\:\\ 0\\.012855730021836282\ \(0\)\
\-\ \\-bone\\:\\ 0\\.012845063300414256\ \(0\)\
\-\ include\\:\\ 0\\.01281900260978763\ \(0\)\
\-\ rule\\:\\ 0\\.01272190499752589\ \(0\)\
\-\ foot\\:\\ 0\\.012592922264629268\ \(0\)\
\-\ hand\\:\\ 0\\.01252126030626532\ \(0\)\
\-\ remembers\\:\\ 0\\.012245291042622432\ \(0\)\
\-\ flag\\:\\ 0\\.012007267169851447\ \(0\)\
\-\ monostotic\\:\\ 0\\.012007267169851447\ \(0\)\
\-\ extremities\\:\\ 0\\.011948971903532578\ \(0\)\
\-\ mineralized\\:\\ 0\\.011797315234635076\ \(0\)\
\-\ 2\\/3\\:\\ 0\\.0116095068288279\ \(0\)\
\-\ occur\\:\\ 0\\.0114297562523406\ \(0\)\
\-\ more\\:\\ 0\\.011428750317177359\ \(0\)\
\-\ bone\\:\\ 0\\.011355265676255989\ \(0\)\
\-\ traversing\\:\\ 0\\.011284512966450085\ \(0\)\
\-\ ollier\\:\\ 0\\.011141834343146098\ \(0\)\
\-\ cortical\\:\\ 0\\.011105436187436049\ \(0\)\
\-\ intensity\\:\\ 0\\.011011303659106242\ \(0\)\
\-\ hyaline\\:\\ 0\\.010886752625426536\ \(0\)\
\-\ typically\\:\\ 0\\.01075374605884482\ \(0\)\
\-\ pop\\:\\ 0\\.010663645418734905\ \(0\)\
\-\ sternum\\:\\ 0\\.010561758763048722\ \(0\)\
\-\ long\\:\\ 0\\.010503463496729853\ \(0\)\
\-\ chondroma\\:\\ 0\\.010465382254545557\ \(0\)\
\-\ allowed\\:\\ 0\\.010373950357241545\ \(0\)\
\-\ heal\\:\\ 0\\.010373950357241545\ \(0\)\
\-\ chondroid\\:\\ 0\\.010373950357241545\ \(0\)\
\-\ less\\:\\ 0\\.010317076664251986\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.010298012114068047\ \(0\)\
\-\ game\\:\\ 0\\.010286980367634714\ \(0\)\
\-\ it\\:\\ 0\\.010271916494828965\ \(0\)\
\-\ equally\\:\\ 0\\.010124820335182439\ \(0\)\
\-\ scapula\\:\\ 0\\.01004895649486373\ \(0\)\
\-\ gliomas\\:\\ 0\\.01004895649486373\ \(0\)\
\-\ carcinomas\\:\\ 0\\.00977417809944972\ \(0\)\
\-\ malignancies\\:\\ 0\\.009711626727237119\ \(0\)\
\-\ known\\:\\ 0\\.009640110818052832\ \(0\)\
\-\ histological\\:\\ 0\\.009481302785205021\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.009481302785205021\ \(0\)\
\-\ approximately\\:\\ 0\\.009425375495741828\ \(0\)\
\-\ go\\:\\ 0\\.009376417758426174\ \(0\)\
\-\ skeleton\\:\\ 0\\.009326202291462367\ \(0\)\
\-\ clavicle\\:\\ 0\\.009229825782959201\ \(0\)\
\-\ healed\\:\\ 0\\.009183523668158382\ \(0\)\
\-\ ulna\\:\\ 0\\.009183523668158382\ \(0\)\
\-\ proximal\\:\\ 0\\.009146321503411818\ \(0\)\
\-\ arises\\:\\ 0\\.00913839388565519\ \(0\)\
\-\ feeling\\:\\ 0\\.009051423896048358\ \(0\)\
\-\ is\\:\\ 0\\.009020707674621268\ \(0\)\
\-\ also\\:\\ 0\\.009008660928717386\ \(0\)\
\-\ football\\:\\ 0\\.00892844195043882\ \(0\)\
\-\ patella\\:\\ 0\\.00892844195043882\ \(0\)\
\-\ resonance\\:\\ 0\\.00892844195043882\ \(0\)\
\-\ vertebrae\\:\\ 0\\.008776645500634351\ \(0\)\
\-\ magnetic\\:\\ 0\\.008740633544631643\ \(0\)\
\-\ appearance\\:\\ 0\\.00871267941794881\ \(0\)\
\-\ syndrome\\:\\ 0\\.00871267941794881\ \(0\)\
\-\ water\\:\\ 0\\.008636767398243095\ \(0\)\
\-\ men\\:\\ 0\\.008603448088061004\ \(0\)\
\-\ likely\\:\\ 0\\.00859283410315742\ \(0\)\
\-\ occurring\\:\\ 0\\.008507071579557839\ \(0\)\
\-\ fibroma\\:\\ 0\\.008476070255650765\ \(0\)\
\-\ fifth\\:\\ 0\\.008357190800216411\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.008357190800216411\ \(0\)\
\-\ in\\:\\ 0\\.008262690787063822\ \(0\)\
\-\ playing\\:\\ 0\\.008115576732486956\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.008066058792902151\ \(0\)\
\-\ signal\\:\\ 0\\.008032350553557143\ \(0\)\
\-\ occasionally\\:\\ 0\\.008017879341230282\ \(0\)\
\-\ called\\:\\ 0\\.007994269311372846\ \(0\)\
\-\ becomes\\:\\ 0\\.007970967918204659\ \(0\)\
\-\ tests\\:\\ 0\\.007970967918204659\ \(0\)\
\-\ equal\\:\\ 0\\.007970967918204659\ \(0\)\
\-\ developing\\:\\ 0\\.007970967918204659\ \(0\)\
\-\ these\\:\\ 0\\.007928145069368413\ \(0\)\
\-\ sensory\\:\\ 0\\.007880693884659642\ \(0\)\
\-\ hands\\:\\ 0\\.007880693884659642\ \(0\)\
\-\ observation\\:\\ 0\\.007815867424462003\ \(0\)\
\-\ once\\:\\ 0\\.007794772134538648\ \(0\)\
\-\ feet\\:\\ 0\\.007794772134538648\ \(0\)\
\-\ a\\:\\ 0\\.007776466702325515\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.007712802235711869\ \(0\)\
\-\ erosion\\:\\ 0\\.0076928854788524655\ \(0\)\
\-\ older\\:\\ 0\\.0076731888011580185\ \(0\)\
\-\ painless\\:\\ 0\\.0076537073920097285\ \(0\)\
\-\ frequent\\:\\ 0\\.007615371910332432\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.007615371910332432\ \(0\)\
\-\ to\\:\\ 0\\.007612622253885673\ \(0\)\
\-\ characteristics\\:\\ 0\\.007577843551691019\ \(0\)\
\-\ resected\\:\\ 0\\.007541089029047996\ \(0\)\
\-\ skeletal\\:\\ 0\\.007522992110217305\ \(0\)\
\-\ hearing\\:\\ 0\\.0075050770730452875\ \(0\)\
\-\ expansion\\:\\ 0\\.0075050770730452875\ \(0\)\
\-\ soft\\:\\ 0\\.00741863373972745\ \(0\)\
\-\ women\\:\\ 0\\.00740121092665674\ \(0\)\
\-\ contour\\:\\ 0\\.0073844734215768116\ \(0\)\
\-\ larger\\:\\ 0\\.007335183704410128\ \(0\)\
\-\ rarely\\:\\ 0\\.0073030651562770105\ \(0\)\
\-\ tissue\\:\\ 0\\.007220752900009246\ \(0\)\
\-\ \\%\\:\\ 0\\.007106313844370793\ \(0\)\
\-\ tumor\\:\\ 0\\.007102432447810378\ \(0\)\
\-\ tubular\\:\\ 0\\.007093113221060642\ \(0\)\
\-\ filled\\:\\ 0\\.007079021991992704\ \(0\)\
\-\ much\\:\\ 0\\.007051169375409672\ \(0\)\
\-\ other\\:\\ 0\\.007021884309099638\ \(0\)\
\-\ small\\:\\ 0\\.007018093705458533\ \(0\)\
\-\ deficits\\:\\ 0\\.006970131275451102\ \(0\)\
\-\ ovarian\\:\\ 0\\.006970131275451102\ \(0\)\
\-\ as\\:\\ 0\\.0069121791759044265\ \(0\)\
\-\ incidentally\\:\\ 0\\.006905304815253465\ \(0\)\
\-\ 21\\:\\ 0\\.0068926177069310686\ \(0\)\
\-\ present\\:\\ 0\\.006880601618294762\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.006867511218728326\ \(0\)\
\-\ generally\\:\\ 0\\.006855089348289657\ \(0\)\
\-\ facial\\:\\ 0\\.006623265590271478\ \(0\)\
\-\ room\\:\\ 0\\.006548760904570121\ \(0\)\
\-\ foci\\:\\ 0\\.006538367107224679\ \(0\)\
\-\ cortex\\:\\ 0\\.006517759580663046\ \(0\)\
\-\ skull\\:\\ 0\\.006487288219951281\ \(0\)\
\-\ suggest\\:\\ 0\\.006487288219951281\ \(0\)\
\-\ addition\\:\\ 0\\.00645732900726611\ \(0\)\
\-\ characteristic\\:\\ 0\\.00644745346292455\ \(0\)\
\-\ limited\\:\\ 0\\.006427865010918141\ \(0\)\
\-\ features\\:\\ 0\\.006427865010918141\ \(0\)\
\-\ general\\:\\ 0\\.006418150920423373\ \(0\)\
\-\ diameter\\:\\ 0\\.006408489481084088\ \(0\)\
\-\ 25\\:\\ 0\\.006157266057499239\ \(0\)\
\-\ range\\:\\ 0\\.006132335144888294\ \(0\)\
\-\ motion\\:\\ 0\\.006124101729814685\ \(0\)\
\-\ symptomatic\\:\\ 0\\.006051663858634959\ \(0\)\
\-\ dysplasia\\:\\ 0\\.006012657243216942\ \(0\)\
\-\ similar\\:\\ 0\\.005974485951766289\ \(0\)\
\-\ change\\:\\ 0\\.005937114956284925\ \(0\)\
\-\ subsequent\\:\\ 0\\.005929733864188612\ \(0\)\
\-\ rare\\:\\ 0\\.005915062742733148\ \(0\)\
\-\ malignancy\\:\\ 0\\.0058860778570437\ \(0\)\
\-\ 50\\:\\ 0\\.0057950053772616835\ \(0\)\
\-\ radiographic\\:\\ 0\\.005781398202831967\ \(0\)\
\-\ emergency\\:\\ 0\\.005767894114046837\ \(0\)\
\-\ tumors\\:\\ 0\\.005721419532389484\ \(0\)\
\-\ greater\\:\\ 0\\.005721419532389484\ \(0\)\
\-\ involvement\\:\\ 0\\.0055827783540602785\ \(0\)\
\-\ calcification\\:\\ 0\\.005529029622918233\ \(0\)\
\-\ risk\\:\\ 0\\.005517302401709601\ \(0\)\
\-\ malignant\\:\\ 0\\.005505651829553121\ \(0\)\
\-\ 20\\:\\ 0\\.005476854253399315\ \(0\)\
\-\ otherwise\\:\\ 0\\.005471150148710062\ \(0\)\
\-\ sclerosis\\:\\ 0\\.005471150148710062\ \(0\)\
\-\ muscle\\:\\ 0\\.005471150148710062\ \(0\)\
\-\ extension\\:\\ 0\\.005437303602819347\ \(0\)\
\-\ complete\\:\\ 0\\.00536074141530491\ \(0\)\
\-\ benign\\:\\ 0\\.0052567742727864545\ \(0\)\
\-\ neoplasm\\:\\ 0\\.005187444876848356\ \(0\)\
\-\ thickening\\:\\ 0\\.005163323653642338\ \(0\)\
\-\ \\(\\:\\ 0\\.005150529242380467\ \(0\)\
\-\ possible\\:\\ 0\\.005130093081789789\ \(0\)\
\-\ areas\\:\\ 0\\.005125396027176589\ \(0\)\
\-\ first\\:\\ 0\\.005111378671632535\ \(0\)\
\-\ \\)\\:\\ 0\\.0050876127779914794\ \(0\)\
\-\ cases\\:\\ 0\\.005074529169306831\ \(0\)\
\-\ swelling\\:\\ 0\\.005074529169306831\ \(0\)\
\-\ out\\:\\ 0\\.005033964129872577\ \(0\)\
\-\ x\\:\\ 0\\.005025073681546305\ \(0\)\
\-\ finding\\:\\ 0\\.004909200543740608\ \(0\)\
\-\ often\\:\\ 0\\.004860024150658917\ \(0\)\
\-\ day\\:\\ 0\\.004835935524693279\ \(0\)\
\-\ between\\:\\ 0\\.004827977782930915\ \(0\)\
\-\ right\\:\\ 0\\.004821559941766934\ \(0\)\
\-\ adjacent\\:\\ 0\\.004816107387048604\ \(0\)\
\-\ and\\:\\ 0\\.004813075019578034\ \(0\)\
\-\ found\\:\\ 0\\.004800402164798774\ \(0\)\
\-\ be\\:\\ 0\\.004697884931707412\ \(0\)\
\-\ the\\:\\ 0\\.004682239588892852\ \(0\)\
\-\ show\\:\\ 0\\.004675857280733736\ \(0\)\
\-\ during\\:\\ 0\\.004661335561361511\ \(0\)\
\-\ age\\:\\ 0\\.004636203788849031\ \(0\)\
\-\ tenderness\\:\\ 0\\.00463264228677653\ \(0\)\
\-\ usually\\:\\ 0\\.004625540559477288\ \(0\)\
\-\ brain\\:\\ 0\\.004583514301787454\ \(0\)\
\-\ years\\:\\ 0\\.004472804165808347\ \(0\)\
\-\ 5\\:\\ 0\\.004456613943750736\ \(0\)\
\-\ y\\.o\\:\\ 0\\.004396398275555615\ \(0\)\
\-\ his\\:\\ 0\\.004390176519869754\ \(0\)\
\-\ when\\:\\ 0\\.004362444273825322\ \(0\)\
\-\ axial\\:\\ 0\\.004347221882473924\ \(0\)\
\-\ through\\:\\ 0\\.004326126592550568\ \(0\)\
\-\ edema\\:\\ 0\\.004308241514137773\ \(0\)\
\-\ he\\:\\ 0\\.004249888310219286\ \(0\)\
\-\ however\\:\\ 0\\.00424129778181296\ \(0\)\
\-\ low\\:\\ 0\\.004235593677123706\ \(0\)\
\-\ high\\:\\ 0\\.004168531303167229\ \(0\)\
\-\ presented\\:\\ 0\\.004152152647098769\ \(0\)\
\-\ one\\:\\ 0\\.00412786342836122\ \(0\)\
\-\ cell\\:\\ 0\\.004114511072337765\ \(0\)\
\-\ cyst\\:\\ 0\\.004093353183647242\ \(0\)\
\-\ cm\\:\\ 0\\.004085483275966107\ \(0\)\
\-\ patients\\:\\ 0\\.003942200711882398\ \(0\)\
\-\ over\\:\\ 0\\.003878150784563213\ \(0\)\
\-\ on\\:\\ 0\\.003871074932435444\ \(0\)\
\-\ consistent\\:\\ 0\\.0037349345255458166\ \(0\)\
\-\ upper\\:\\ 0\\.0036757228259691947\ \(0\)\
\-\ into\\:\\ 0\\.003624467679072561\ \(0\)\
\-\ man\\:\\ 0\\.003602374051853831\ \(0\)\
\-\ imaging\\:\\ 0\\.0035687590453754056\ \(0\)\
\-\ can\\:\\ 0\\.0034549418047576997\ \(0\)\
\-\ lower\\:\\ 0\\.003425779089775156\ \(0\)\
\-\ but\\:\\ 0\\.003248668985799532\ \(0\)\
\-\ multiple\\:\\ 0\\.003208210344882832\ \(0\)\
\-\ after\\:\\ 0\\.0031515172952035694\ \(0\)\
\-\ no\\:\\ 0\\.0030675370791579393\ \(0\)\
\-\ of\\:\\ 0\\.0029074032284702993\ \(0\)\
\-\ within\\:\\ 0\\.0029057600862496995\ \(0\)\
\-\ with\\:\\ 0\\.0027113267186605465\ \(0\)\
\-\ disease\\:\\ 0\\.002489728237461148\ \(0\)\
\-\ not\\:\\ 0\\.002201102801679029\ \(0\)\
\-\ an\\:\\ 0\\.002106354481790962\ \(0\)\
\-\ at\\:\\ 0\\.0020637489355287576\ \(0\)\
\-\ \\:\\:\\ 0\\.002014750117630419\ \(0\)\
\-\ \\.\\:\\ 0\\.0018983709142965921\ \(0\)\
\-\ pain\\:\\ 0\\.0018602641132455164\ \(0\)\
\-\ this\\:\\ 0\\.0017132570647310748\ \(0\)\
